Establishment Labs Holdings Inc. (NASDAQ:ESTA) Stake Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 89.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 41,351 shares of the company’s stock after purchasing an additional 19,531 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Establishment Labs were worth $1,789,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in ESTA. Hood River Capital Management LLC acquired a new position in Establishment Labs during the 2nd quarter worth $43,000. Nkcfo LLC acquired a new stake in Establishment Labs in the second quarter worth about $227,000. SG Americas Securities LLC bought a new position in Establishment Labs in the 2nd quarter valued at about $303,000. Black Swift Group LLC bought a new position in Establishment Labs in the 3rd quarter valued at about $312,000. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in Establishment Labs during the 2nd quarter valued at about $373,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. BTIG Research upped their price target on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Citigroup upped their target price on Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Finally, Stephens upgraded Establishment Labs to a “strong-buy” rating in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Stock Up 0.6 %

NASDAQ ESTA opened at $46.00 on Monday. Establishment Labs Holdings Inc. has a 12 month low of $22.55 and a 12 month high of $60.12. The company has a market capitalization of $1.29 billion, a P/E ratio of -17.83 and a beta of 1.16. The company’s 50 day simple moving average is $43.63 and its 200 day simple moving average is $44.04. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.